This is a randomized, double-blind, placebo-controlled, dose ranging pilot study to examine the effects of conivaptan in patients with acute decompensated heart failure.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
170
IV
IV
Change from baseline in respiratory Visual analog Scale (VAS)
Time frame: 48 hours
Change from baseline in global VAS
Time frame: 48 hours
Total urine output vs. baseline
Time frame: 72 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The Heart Center, P.C.
Huntsville, Alabama, United States
LA County/USC Medical Center
Los Angeles, California, United States
San Joaquin Cardiology
Manteca, California, United States
Apex Research Institute
Santa Ana, California, United States
The Greater Fort Lauderdale Heart Group Research
Fort Lauderdale, Florida, United States
Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
U. Miami, Jackson Mem'l Medical Center
Miami, Florida, United States
Discovery Medical Research Group
Ocala, Florida, United States
Rush-Presbyterian St. Luke's Medical Center
Chicago, Illinois, United States
Louisiana State University Medical Center School of Medicine
New Orleans, Louisiana, United States
...and 16 more locations